about
Stem cell therapy for heart failure: Ensuring regenerative proficiencyThe protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stressSuppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazineCardioprotection and ageingmIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart.Endothelial ischemia-reperfusion injury in humans: association with age and habitual exercise.Frequent periodic leg movement during sleep is an unrecognized risk factor for progression of atrial fibrillation.SIRT1-mediated acute cardioprotection.Ischemic preconditioning: the role of mitochondria and agingExogenous hydrogen sulfide restores cardioprotection of ischemic post-conditioning via inhibition of mPTP opening in the aging cardiomyocytes.Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities.Exogenous H2S contributes to recovery of ischemic post-conditioning-induced cardioprotection by decrease of ROS level via down-regulation of NF-κB and JAK2-STAT3 pathways in the aging cardiomyocytes.Secondhand Smoke Exposure Reduced the Compensatory Effects of IGF-I Growth Signaling in the Aging Rat Hearts.Mechanisms of arrhythmias and conduction disorders in older adults.Caveolin and caveolae in age associated cardiovascular diseaseMicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart.Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction.In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycineAge-related reduction of cerebral ischemic preconditioning: myth or reality?Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm.Cardioprotection by metabolic shut-down and gradual wake-up.Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress.Molecular aspects of the cardioprotective effect of exercise in the elderly.Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly.The role of extracellular matrix in age-related conduction disorders: a forgotten player?What is hormesis and its relevance to healthy aging and longevity?The Citrus Flavanone Naringenin Produces Cardioprotective Effects in Hearts from 1 Year Old Rat, through Activation of mitoBK Channels.Clinical application of ischemic preconditioning in the elderly.Risk factors of postcardiotomy ventricular dysfunction in moderate-to-high risk patients undergoing open-heart surgery.Investigation of thrombospondin-1 and transforming growth factor-β expression in the heart of aging mice.Pretreatment with hemoglobin-based oxygen carriers protect isolated rat heart from myocardial infarction.Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.Hypoxia-inducible factor-1 improves inotropic responses of cardiac myocytes in ageing heart without affecting mitochondrial activity.Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.Simulated ischemia-induced preconditioning of isolated ventricular myocytes from young adult and aged Fischer-344 rat hearts.Preoperative Short-Term Calorie Restriction for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Open-Label, Pilot Trial.Enhanced basal late sodium current appears to underlie the age-related prolongation of action potential duration in guinea pig ventricular myocytes.Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury.L-Glycyl-L-glutamine provides the isolated and perfused young and middle-aged rat heart protection against ischaemia-reperfusion injury.
P2860
Q26750516-6DF84E91-D5BA-4B45-960C-364C6B8A6C4BQ26822734-1B9B8A2C-0A49-42F2-8F8A-2A22AD5A5398Q30622882-328EB05A-837E-44F8-9813-EEC81CF95AA0Q33861492-76C6A5B3-A59E-47CC-BC82-AA71D2FF7915Q34229899-8861B401-2A99-431D-A7DF-16499FD30306Q34720322-31D2817E-FE58-40ED-B91E-793E48713FD0Q35023591-675D5266-01CF-41F7-8749-CB7A06C1FAE5Q35395805-5E8B9222-E6EA-4595-A32A-F48FD92A6A1BQ35631620-EBEC4567-A85F-4121-9155-1D5D2B800A75Q35902926-5965FD3C-9B9C-418E-A2F1-D90C35E1ABF6Q35964222-EC52E6D8-482A-4AA6-BBC1-F1F21EF3077BQ35994514-AEE39023-55EB-45A1-9968-A0292B1EC428Q36064274-01F2D85A-2055-460A-B367-11A40723E4AEQ36723709-6EFBA598-C0AC-408C-BA53-F4587423FA7DQ36769820-CFCD12D4-A04B-4359-A04E-8AE453812AA3Q36795205-5D1E1A9A-8B2E-4771-B071-302E2055557FQ36938437-5A40FDB8-2C65-4450-A33A-A2BAAFA1C9DFQ37195014-B802142A-882B-4879-B6A1-EAB1D8696538Q37278544-1163C24A-3B57-4B68-AB38-18900E425627Q37344448-5E9AEE78-69E1-4B45-90AD-1E899BED5D10Q37414476-AA5C3572-5E3D-42CA-B98C-63C4DCF533CCQ37430956-E2DC8F14-62C6-44CD-9CDB-1CED0D8D5DD6Q38129354-3A26D270-62B2-448F-B2B2-BD34C1286B28Q38155933-BD379C2E-D420-4FAE-BAC9-F4E4BF634337Q38354482-B701BC47-EAA9-4B7E-85C3-67A3C490ED8AQ38582970-13C80EC8-F7EC-4C81-9896-5293B709D91BQ38910312-D2940ED4-6D76-4B16-9A0B-BF1B8CEEF4EAQ39542900-2A698BD3-B9DC-4E78-96F6-7FF86DD8B176Q41178857-856D1277-18D8-43E1-8907-08B136FBABF3Q41983986-C4D626B7-DD3E-422C-92B9-62C95F0FCFB5Q42468920-189C7DA6-337B-44A5-A3ED-7E8F5B3FCCCAQ42516922-B9997C85-9328-445E-A5E1-CBA9D721304AQ43130316-B0706542-9B2C-4FFF-A471-14FA91B752C8Q46309781-845C9E15-78A6-4A4B-9E5A-D3EA0DBF4483Q50458427-6175AD5C-D4DD-4C86-A94B-92F0F5A53A33Q51763482-99731196-EBC9-4971-AC91-0552A3C2AAE0Q51772816-A43201BA-E0B8-4087-98D8-D95F35AB1277Q53207443-1F9FDD34-1D4D-4BB1-8ED4-AB8342802FEDQ53515086-99FFDD20-39BF-4C72-8342-CFC3C4FC85B6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aging and cardioprotection.
@en
type
label
Aging and cardioprotection.
@en
prefLabel
Aging and cardioprotection.
@en
P2093
P2860
P1476
Aging and cardioprotection.
@en
P2093
Andre Terzic
Arshad Jahangir
Sandeep Sagar
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00647.2007
P407
P577
2007-08-23T00:00:00Z